ITM Power's 7% MSCI Slump Puts the Focus on a June Packed with Binary Catalysts

A classic “buy the rumour, sell the fact” greeted ITM Power on the day it joined the MSCI United Kingdom Small Cap Index. On 29 May, the shares slid seven percent to 194.40 pence after touching a 52-week peak of 219.80 pence, with almost 27.6 million shares changing hands — more than four times the daily average. That noise, however, masks a far more consequential story: three binary events in June that will determine whether the hydrogen pure?play can translate a blistering rally into industrial reality.

The most pivotal is the final investment decision on Chronos, a fully?automated gigawatt manufacturing line at the company’s Sheffield facility. The project is backed by an £86.5 million government package, with Great British Energy contributing £40 million in equity and the Department for Energy Security and Net Zero providing a £46.5 million grant that will be disbursed over the 2026/27 and 2027/28 fiscal years. The Competition and Markets Authority gave the green light on 20 May, removing the final regulatory hurdle. The new 2?MW electrolyser unit at the heart of Chronos triples the power of its predecessor while cutting manufacturing costs by 40 percent and halving the physical footprint. Component count drops by half, 90 percent of materials are recyclable, and power density rises to 2.5 MW per square metre. Management has said the decision will follow formal completion of the grant agreement.

A second binary trigger is the outcome of the UK’s second hydrogen allocation round, HAR2, which has 27 projects on the shortlist. ITM Power is the preferred supplier for two of them, one large and one smaller, though both hinge on final investment decisions by their developers. Among the contenders is Uniper’s Humber H2ub in Killingholme, for which ITM could supply six 20?MW Poseidon modules in a first 120?MW phase. The unit is scheduled to enter service in 2029 and could later expand beyond 200 MW. The government expects to award contracts by the end of 2026, but informal signals could emerge as early as June. A positive verdict would significantly swell the current order book of £152 million — 71 percent of which is already deemed profitable.

Third, the operationally focused CEO, Dennis Schulz, has his own compensation tied entirely to these milestones: 1.3 million shares only vest upon successful delivery of Chronos and the signing of profitable contracts. That alignment contrasts with a notable insider sale by technology chief Simon Bourne, who sold most of his 1.3 million option holdings at an average of 157.44 pence, citing tax obligations. He retains around 656,000 shares.

Should investors sell immediately? Or is it worth buying ITM Power?

The analyst community is deeply split on valuation. Jefferies has a “Buy” rating and a 200?pence target but warns that a negative Chronos outcome could cost the stock 52 percent of its value. Berenberg also rates the shares a “Buy” but trimmed its target to 110 pence. UBS is neutral at 60 pence. Morgan Stanley upgraded the stock to “Overweight” — the first positive rating on a UK hydrogen name since 2021 — and sees EBITDA breakeven as early as financial year 2028, a year ahead of consensus, provided ITM books roughly 200 MW of new orders. Overall, seven of 12 analysts covering the stock recommend buying.

Operational momentum is picking up, albeit from a low base. Revenue for the current financial year 2026 is forecast at £40?43 million, a 35 percent increase. The first half already delivered a record £18 million in sales, while the adjusted EBITDA loss narrowed to £11.9 million from £16.8 million a year earlier. The full?year EBITDA deficit is still expected at £27?29 million, and the pre?tax loss widened to £45.4 million. Yet the balance sheet has been transformed. Following the Great British Energy injection, year?end net liquidity guidance was lifted to £210?215 million from a prior range of £170?175 million. The company sits on almost £200 million in cash with zero debt, giving it ample runway through the end of the decade without tapping equity markets.

Ahead of the Chronos decision, a secondary project called REFHYNE?2 has supplied useful validation. The 100?MW PEM electrolyser at Shell’s Energy and Chemicals Park in Rheinland won two categories at the World Hydrogen Awards 2026 in Rotterdam: “Clean Hydrogen Project” and recognition for industrial application. The facility is designed to produce up to 44,000 kilograms of renewable hydrogen per day from 2027, partly to decarbonise fuel production at Shell’s neighbouring Wesseling refinery. For ITM, it is an important reference that demonstrates its technology can function at commercial scale.

ITM Power at a turning point? This analysis reveals what investors need to know now.

All three June catalysts will converge when ITM Power publishes its full?year results on 15 September. By then, the Chronos investment decision will be made, the HAR2 winners will be known, and Uniper’s stance on Humber H2ub should be clearer. After a rally that has more than doubled the stock from its lows, the coming weeks will determine whether the rally has real substance — or whether the market has simply been buying a story that has yet to deliver.

Ad

ITM Power Stock: New Analysis - 3 June

Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated ITM Power analysis...

en | GB00B0130H42 | ITM | boerse | 69474779 |